Inmode Ltd INMD

NAS: INMD | ISIN: IL0011595993   30/04/2025
14,10 USD (-2,22%)
(-2,22%)   30/04/2025

28 april 2025 · InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million Represents 3% Year-Over-Year Decrease · Persbericht

14 april 2025 · InMode to Report First Quarter 2025 Financial Results and Hold Conference Call on April 28, 2025, Expects Q1 Revenue Between $77.2M-$77.5M, Reiterates FY 2025 Revenue Guidance Between $395M-$405M · Persbericht

26 maart 2025 · InMode to Present at the 24th Annual Needham Virtual Healthcare Conference · Persbericht

6 maart 2025 · InMode Responds to Doma Perpetual's Letters · Persbericht

3 maart 2025 · InMode to Present at Upcoming Investor Conferences · Persbericht

10 september 2024 · InMode Announces Share Repurchase Program of Up to 7.68 Million Shares · Persbericht

4 september 2024 · InMode to Present at 2024 Baird Global Healthcare Conference · Persbericht

6 augustus 2024 · InMode to Present at Upcoming Investor Conferences · Persbericht

1 augustus 2024 · InMode Reports Second Quarter 2024 Financial Results; Quarterly Revenue of $86.4M Represents 36.5% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet delivered) of $102.6M · Persbericht

31 juli 2024 · InMode Introduces IgniteRF The Complete Minimally Invasive Soft Tissue Contraction Platform · Persbericht

25 juli 2024 · DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer · Persbericht

17 juli 2024 · Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling · Persbericht

11 juli 2024 · InMode to Report Second Quarter 2024 Financial Results and Hold Conference Call on Aug. 1, 2024 · Persbericht

16 mei 2024 · InMode to Present at Jefferies Healthcare Conference · Persbericht

8 mei 2024 · InMode Announces P1 Offshore Racing Partnership with Female Driver Victoria Rand · Persbericht

2 mei 2024 · InMode Reports First Quarter 2024 Financial Results; Quarterly Revenue of $80.3M Represents 24% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet available) of $96M; · Persbericht

15 april 2024 · InMode Responds To BTL Petition for Inter Partes Review Of Patent InMode Is Asserting Against BTL · Persbericht

15 april 2024 · Shareholders of InMode Ltd. Should Contact Levi & Korsinsky Before April 15, 2024 to Discuss Your Rights - INMD · Persbericht

13 april 2024 · INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of InMode · Persbericht

10 april 2024 · InMode Ltd. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - INMD · Persbericht

Mijn selecties